{"id":779,"date":"2022-07-06T08:32:23","date_gmt":"2022-07-06T08:32:23","guid":{"rendered":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=779"},"modified":"2022-07-06T08:32:23","modified_gmt":"2022-07-06T08:32:23","slug":"nota-informativa-muh-fv-4-2022","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2022\/07\/06\/nota-informativa-muh-fv-4-2022\/","title":{"rendered":"Nota Informativa MUH (FV), 4\/2022"},"content":{"rendered":"<p><a href=\"https:\/\/www.aemps.gob.es\/informa\/notasinformativas\/medicamentosusohumano-3\/seguridad-1\/2022\/adrenalina-level-1mg-ml-solucion-inyectable-en-jeringa-precargada-incompatibilidad-de-administracion-directa-a-traves-de-los-sistemas-clave-microclave\/\">Adrenalina Level 1mg\/ml soluci\u00f3n inyectable en jeringa precargada: incompatibilidad de administraci\u00f3n directa a trav\u00e9s de los sistemas Clave\/MicroClave<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adrenalina Level 1mg\/ml soluci\u00f3n inyectable en jeringa precargada: incompatibilidad de administraci\u00f3n directa a trav\u00e9s de los sistemas Clave\/MicroClave<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-779","post","type-post","status-publish","format-standard","hentry","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=779"}],"version-history":[{"count":1,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/779\/revisions"}],"predecessor-version":[{"id":780,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/779\/revisions\/780"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}